GDC-0879   Click here for help

GtoPdb Ligand ID: 5681

Synonyms: AR 00341677 | AR00341677 | GDC 0879 | GDC0879
PDB Ligand
Compound class: Synthetic organic
Comment: GDC-0879 is an inhibitor of B-Raf proto-oncogene (BRAF), serine/threonine kinase [2]. It was a preclinical lead compound. PubChem includes four alternative tautomeric forms of this compound. Most sources are linked to CID 11717001 but some assay resulls are linked to CID 57519545. This has a Probe Portal entry SGC GDC-0879
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 83.53
Molecular weight 334.14
XLogP 2.15
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCn1cc(c(n1)c1ccncc1)c1ccc2c(c1)CCC2=NO
Isomeric SMILES OCCn1cc(c(n1)c1ccncc1)c1ccc2c(c1)CC/C/2=N\O
InChI InChI=1S/C19H18N4O2/c24-10-9-23-12-17(19(21-23)13-5-7-20-8-6-13)15-1-3-16-14(11-15)2-4-18(16)22-25/h1,3,5-8,11-12,24-25H,2,4,9-10H2/b22-18+
InChI Key DEZZLWQELQORIU-RELWKKBWSA-N
Bioactivity Comments
GDC-0879 exhibits good preclinical in vivo activity in tumour xenograft models [2]. Off-target effects are known for the related serine/threonine kinase, c-Raf (Raf-1 proto-oncogene ot RAF1) [2].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
B-Raf proto-oncogene, serine/threonine kinase Primary target of this compound Hs Inhibitor Inhibition 9.7 – 9.9 pIC50 - 1-2
pIC50 9.7 – 9.9 (IC50 1.9x10-10 – 1.3x10-10 M) [1-2]